Obesity, Diabetes, and Risk of Parkinson's Disease

被引:151
作者
Palacios, Natalia [1 ]
Gao, Xiang [1 ,5 ,6 ]
McCullough, Marjorie L. [2 ]
Jacobs, Eric J. [2 ]
Patel, Alpa V. [2 ]
Mayo, Tinisha [2 ]
Schwarzschild, Michael A. [3 ]
Ascherio, Alberto [1 ,4 ,5 ,6 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
obesity; diabetes; Parkinson's disease; body mass index; CORONARY-HEART-DISEASE; BODY-MASS INDEX; PHYSICAL-ACTIVITY; PROSPECTIVE COHORT; CANCER; INSULIN; HYPOTHALAMUS; METAANALYSIS; OVERWEIGHT; MORTALITY;
D O I
10.1002/mds.23855
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
The aim of this work was to investigate whether obesity and diabetes are related to risk of Parkinson's disease. We prospectively followed 147,096 participants in the Cancer Prevention Study II Nutrition Cohort from 1992 to 2005. Participants provided information on anthropometric variables and medical history at baseline and on waist circumference in 1997. Incident cases of Parkinson's disease (n = 656) were confirmed by treating neurologists and medical record review. Relative risks were estimated using proportional hazards models, adjusting for age, gender, smoking, and other risk factors. Neither body mass index nor waist circumference significantly predicted Parkinson's disease risk. Relative risk comparing individuals with a baseline body mass index of >= 30 to those with a body mass index <23 was 1.00 (95% confidence interval: 0.75, 1.34; P trend: 0.79), and that comparing individuals with a waist circumference in the top category (>= 40.3 inches in men and >= 35 inches in women) to those in the bottom category (<34.5 inches in men and <28 inches in women) was 1.35 (95% confidence interval: 0.95, 1.93; P trend: 0.08). History of diabetes was not significantly associated with Parkinson's disease risk (combined relative risks = 0.88; 95% confidence interval: 0.62, 1.25; P heterogeneity = 0.96). In addition, neither body mass index at age 18 nor changes in weight between age 18 and baseline were significantly associated with Parkinson's disease risk. The results did not differ significantly by gender. Our results do not provide evidence for a relationship between body mass index, weight change, waist circumference, or baseline diabetes and risk of Parkinson's disease. (C) 2011 Movement Disorder Society
引用
收藏
页码:2253 / 2259
页数:7
相关论文
共 30 条
[1]
Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[2]
Pesticide exposure and risk for Parkinson's disease [J].
Ascherio, Alberto ;
Chen, HonPei ;
Weisskopf, Marc G. ;
O'Reilly, Eilis ;
McCullough, Marjorie L. ;
Calle, Eugenia E. ;
Schwarzschild, Michael A. ;
Thun, Michael J. .
ANNALS OF NEUROLOGY, 2006, 60 (02) :197-203
[3]
The American Cancer Society cancer prevention study II nutrition cohort - Rationale, study design, and baseline characteristics [J].
Calle, EE ;
Rodriguez, C ;
Jacobs, EJ ;
Almon, ML ;
Chao, A ;
McCullough, ML ;
Feigelson, HS ;
Thun, MJ .
CANCER, 2002, 94 (09) :2490-2501
[4]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[5]
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease [J].
Chen, HL ;
Jacobs, E ;
Schwarzschild, MA ;
McCullough, ML ;
Calle, EE ;
Thun, MJ ;
Ascherio, A .
ANNALS OF NEUROLOGY, 2005, 58 (06) :963-967
[6]
Obesity and the risk of Parkinson's disease [J].
Chen, HL ;
Zhang, SMM ;
Schwarzschild, MA ;
Hernán, MA ;
Willett, WC ;
Ascherio, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (06) :547-555
[7]
Insulin and neurodegenerative disease: shared and specific mechanisms [J].
Craft, S ;
Watson, GS .
LANCET NEUROLOGY, 2004, 3 (03) :169-178
[8]
METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease [J].
Driver, Jane A. ;
Smith, Ashley ;
Burning, Julie E. ;
Gaziano, J. Michael ;
Kurth, Tobias ;
Logroscino, Giancarlo .
DIABETES CARE, 2008, 31 (10) :2003-2005
[10]
An 18-year follow-up of overweight and risk of Alzheimer disease [J].
Gustafson, D ;
Rothenberg, E ;
Blennow, K ;
Steen, B ;
Skoog, I .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1524-1528